Press release
Bronchitis Pipeline Appears Robust With 15+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
DelveInsight's, "Bronchitis Pipeline Insight 2025" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Bronchitis pipeline landscape. It covers the Bronchitis Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bronchitis Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.Explore the comprehensive insights by DelveInsight and stay ahead in understanding the C Bronchitis Treatment Landscape. Click here to read more @ Bronchitis Pipeline Outlook- https://www.delveinsight.com/sample-request/bronchitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Bronchitis Pipeline Report
• In April 2025, Incyte Corporation announced a study will be conducted to compare the efficacy of axatilimab versus placebo in combination with corticosteroids as initial treatment for moderate or severe chronic graft-versus-host disease (cGVHD).
• In April 2025, Kadmon, a Sanofi Company announced a Phase 2, open-label, long-term treatment and follow-up study in subjects with cGVHD who have been previously treated with belumosudil in Study KD025-208 or Study KD025-213. Subjects will not be screened.
• DelveInsight's Bronchitis pipeline report depicts a robust space with 15+ active players working to develop 15+ pipeline therapies for Bronchitis treatment.
• The leading Bronchitis Companies such as Zambon SpA, Yuhan Corporation, Theravance Biopharma, Genentech, Inc., GlaxoSmithKline, Novartis, SolAeroMed Inc., Reata Pharmaceuticals, Inc., Pulmatrix, Pharmaxis, PharmaKing, NovaBiotics, Merck Sharp & Dohme Corp., Johnson & Johnson Pharmaceutical Research & Development, Ionis Pharmaceuticals, Inc., Incyte Corporation, EmeraMed, Daewon Pharmaceutical Co., Ltd., Chong Kun Dang Pharmaceutical, Breath Therapeutics Inc., Boehringer Ingelheim, BioMarck Pharmaceuticals, Beyond Air, AstraZeneca, APT Pharmaceuticals, Inc., Abgenix, Abbott and others.
• Promising Bronchitis Pipeline Therapies such as BN101, TQ05105 Tablet, Belumosudil, Rituximab, Prednisone, TDI01 suspension, INCA034176, Corticosteroids and others.
Discover groundbreaking developments in Bronchitis Therapies! Gain in-depth knowledge of key Bronchitis Clinical trials, emerging drugs, and market opportunities @ Bronchitis Clinical Trials Assessment- https://www.delveinsight.com/sample-request/bronchitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Bronchitis Emerging Drugs Profile
• DW 1601: Daewon Pharmaceutical
Daewon Pharmaceutical is developing DW 1601 for the treatment of Bronchitis.
The Bronchitis Pipeline Report Provides Insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Bronchitis with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Bronchitis Treatment.
• Bronchitis Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Bronchitis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Bronchitis Market
Stay informed about the Bronchitis Pipeline trends! Uncover critical updates on therapeutic innovations and their potential impact on patients and the healthcare industry @ Bronchitis Unmet Needs- https://www.delveinsight.com/sample-request/bronchitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Bronchitis Companies
Zambon SpA, Yuhan Corporation, Theravance Biopharma, Genentech, Inc., GlaxoSmithKline, Novartis, SolAeroMed Inc., Reata Pharmaceuticals, Inc., Pulmatrix, Pharmaxis, PharmaKing, NovaBiotics, Merck Sharp & Dohme Corp., Johnson & Johnson Pharmaceutical Research & Development, Ionis Pharmaceuticals, Inc., Incyte Corporation, EmeraMed, Daewon Pharmaceutical Co., Ltd., Chong Kun Dang Pharmaceutical, Breath Therapeutics Inc., Boehringer Ingelheim, BioMarck Pharmaceuticals, Beyond Air, AstraZeneca, APT Pharmaceuticals, Inc., Abgenix, Abbott and others.
Bronchitis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Infusion
• Intradermal
• Intramuscular
• Intranasal
• Oral
• Parenteral
• Subcutaneous
• Topical.
• Molecule Type
Bronchitis Products have been categorized under various Molecule types such as
• Vaccines
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Product Type
Transform your understanding of the Bronchitis Pipeline! See the latest progress in drug development and clinical research @ Bronchitis Market Drivers and Barriers, and Future Perspectives- https://www.delveinsight.com/sample-request/bronchitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Bronchitis Pipeline Report
• Coverage- Global
• Bronchitis Companies- Zambon SpA, Yuhan Corporation, Theravance Biopharma, Genentech, Inc., GlaxoSmithKline, Novartis, SolAeroMed Inc., Reata Pharmaceuticals, Inc., Pulmatrix, Pharmaxis, PharmaKing, NovaBiotics, Merck Sharp & Dohme Corp., Johnson & Johnson Pharmaceutical Research & Development, Ionis Pharmaceuticals, Inc., Incyte Corporation, EmeraMed, Daewon Pharmaceutical Co., Ltd., Chong Kun Dang Pharmaceutical, Breath Therapeutics Inc., Boehringer Ingelheim, BioMarck Pharmaceuticals, Beyond Air, AstraZeneca, APT Pharmaceuticals, Inc., Abgenix, Abbott and others.
• Bronchitis Pipeline Therapies- BN101, TQ05105 Tablet, Belumosudil, Rituximab, Prednisone, TDI01 suspension, INCA034176, Corticosteroids and others.
• Bronchitis Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Bronchitis Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Stay Ahead in Respiratory Disease Research-Access the Full Bronchitis Pipeline Analysis Today! @ Bronchitis Drugs and Companies- https://www.delveinsight.com/sample-request/bronchitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Contents
1. Introduction
2. Executive Summary
3. Bronchitis: Overview
4. Causes
5. Mechanism of Action
6. Signs and Symptoms
7. Diagnosis
8. Disease Management
9. Pipeline Therapeutics
10. Comparative Analysis
11. Therapeutic Assessment
12. Assessment by Product Type
13. Assessment by Stage and Product Type
14. Assessment by Route of Administration
15. Assessment by Stage and Route of Administration
16. Assessment by Molecule Type
17. Assessment by Stage and Molecule Type
18. Bronchitis - DelveInsight's Analytical Perspective
19. In-depth Commercial Assessment
20. Bronchitis companies' collaborations, Licensing, Acquisition -Deal Value Trends
21. Bronchitis Collaboration Deals
22. Company-Company Collaborations (Licensing / Partnering) Analysis
23. Company-University Collaborations (Licensing / Partnering) Analysis
24. Late Stage Products (Phase III)
25. Comparative Analysis
26. DW 1601: Daewon Pharmaceutical
27. Product Description
28. Research and Development
29. Product Development Activities
30. Drug profiles in the detailed report.....
31. Mid Stage Products (Phase II)
32. Comparative Analysis
33. Drug Name: Company Name
34. Product Description
35. Research and Development
36. Product Development Activities
37. Drug profiles in the detailed report.....
38. Early Stage Products (Phase I)
39. Comparative Analysis
40. Drug Name: Company Name
41. Product Description
42. Research and Development
43. Product Development Activities
44. Drug profiles in the detailed report.....
45. Pre-clinical and Discovery Stage Products
46. Comparative Analysis
47. Drug Name: Company Name
48. Product Description
49. Research and Development
50. Product Development Activities
51. Drug profiles in the detailed report.....
52. Inactive Products
53. Comparative Analysis
54. Bronchitis Key Companies
55. Bronchitis Key Products
56. Bronchitis- Unmet Needs
57. Bronchitis- Market Drivers and Barriers
58. Bronchitis- Future Perspectives and Conclusion
59. Bronchitis Analyst Views
60. Bronchitis Key Companies
61. Appendix
List of Top Selling Market Research Reports in 2025
Antibody Drug Conjugate Market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Attention Deficit Hyperactivity Disorder Market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Avascular Necrosis Market- https://www.delveinsight.com/report-store/avascular-necrosis-market
Bacterial Pneumonia Market- https://www.delveinsight.com/report-store/bacterial-pneumonia-market
Brucellosis Market- https://www.delveinsight.com/report-store/brucellosis-market
Carbapenem-resistant Enterobacteriaceae Infection Market- https://www.delveinsight.com/report-store/carbapenem-resistant-enterobacteriaceae-infection-market
Central Retinal Vein Occlusion Market- https://www.delveinsight.com/report-store/retinal-vein-occlusion-market
Chagas Disease Market- https://www.delveinsight.com/report-store/chagas-disease-market
Cone Rod Dystrophy Market- https://www.delveinsight.com/report-store/cone-rod-dystrophy-market
Digestive System Fistula Market- https://www.delveinsight.com/report-store/digestive-system-fistula-market
Elastomeric Pump Market- https://www.delveinsight.com/report-store/elastomeric-pump-market
Embolotherapy Market- https://www.delveinsight.com/report-store/embolotherapy-market
Ewing Sarcoma Market- https://www.delveinsight.com/report-store/ewing-sarcoma-market
Familial Lipoprotein Lipase Deficiency Pipeline- https://www.delveinsight.com/report-store/familial-lipoprotein-lipase-deficiency-pipeline-insight
Gastroparesis Market- https://www.delveinsight.com/report-store/gastroparesis-market
Graves Disease Market- https://www.delveinsight.com/report-store/graves-disease-market
Hdac Inhibitors Market- https://www.delveinsight.com/report-store/hdac-inhibitor-pipeline-insight
Hip Replacement Devices Market- https://www.delveinsight.com/report-store/hip-reconstruction-devices-market
Immune Checkpoints Activator Companies- https://www.delveinsight.com/report-store/immune-checkpoints-activators
Japan Healthcare Outlook- https://www.delveinsight.com/report-store/japan-healthcare-outlook-report
Meibomian Gland Dysfunction Market- https://www.delveinsight.com/report-store/meibomian-gland-dysfunction-market
Moderate To Severe Plaque Psoriasis Market- https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-market
Neurodermatitis Market- https://www.delveinsight.com/report-store/neurodermatitis-market
Neurofibromatosis Type 2 Market- https://www.delveinsight.com/report-store/neurofibromatosis-type-2-market-insight
Nk Cell Therapy Market- https://www.delveinsight.com/report-store/nk-cell-therapy-pipeline-insight
Nocturia Market- https://www.delveinsight.com/report-store/nocturia-market
Non-muscle Invasive Bladder Cancer Market- https://www.delveinsight.com/report-store/non-muscle-invasive-bladder-cancer-market
Nonalcoholic Steatohepatitis Market- https://www.delveinsight.com/report-store/nonalcoholic-steatohepatitis-nash-market
Opioid-related Disorders Market- https://www.delveinsight.com/report-store/opioid-related-disorders-market
Palmar Fibromatosis Market- https://www.delveinsight.com/report-store/palmar-fibromatosis-market
Peanut Allergy Market- https://www.delveinsight.com/report-store/peanut-allergy-market
Pediatric Growth Hormone Deficiency Market- https://www.delveinsight.com/report-store/pediatric-growth-hormone-deficiency-market
Perennial Allergic Rhinitis Market- https://www.delveinsight.com/report-store/perennial-allergic-rhinitis-market
Phototherapies For Psoriasis Market- https://www.delveinsight.com/report-store/phototherapy-devices-market
Pleural Effusion Market- https://www.delveinsight.com/report-store/pleural-effusion-market
Postpartum Depression Market- https://www.delveinsight.com/report-store/postpartum-depression-ppd-market
Primary Mediastinal Large B-cell Lymphoma Market- https://www.delveinsight.com/report-store/primary-mediastinal-large-b-cell-lymphoma-market
Psoriasis Vulgaris Market- https://www.delveinsight.com/report-store/psoriasis-vulgaris-market
Relapsing Refractory Multiple Myeloma Market- https://www.delveinsight.com/report-store/relapsing-refractory-multiple-myeloma-market
Restless Legs Syndrome Market- https://www.delveinsight.com/report-store/restless-leg-syndrome-market
Rosacea Market - https://www.delveinsight.com/report-store/rosacea-market
Scabies Market- https://www.delveinsight.com/report-store/scabies-market
Seasonal Allergic Rhinitis Market- https://www.delveinsight.com/report-store/allergic-rhinitis-market
Surgical Bleeding Market- https://www.delveinsight.com/report-store/surgical-bleeding-market
Syphilis Market- https://www.delveinsight.com/report-store/syphilis-market
Systemic Inflammatory Response Syndrome Market- https://www.delveinsight.com/report-store/systemic-inflammatory-response-syndrome-market
Tay-sachs Market- https://www.delveinsight.com/report-store/tay-sachs-disease-market
Tendinopathy Market- https://www.delveinsight.com/report-store/tendinopathy-market
Tendonitis Market- https://www.delveinsight.com/report-store/tendonitis-market
Trauma Fixation Devices Market- https://www.delveinsight.com/report-store/trauma-devices-market
Trichotillomania Market- https://www.delveinsight.com/report-store/trichotillomania-ttm-market
Uncomplicated Urinary Tract Infection Market- https://www.delveinsight.com/report-store/uncomplicated-urinary-tract-infection-uuti-market
Urinary Retention Market- https://www.delveinsight.com/report-store/urinary-retention-market
Urothelial Carcinoma Market- https://www.delveinsight.com/report-store/urothelial-carcinoma-market
Uveitis Market- https://www.delveinsight.com/report-store/uveitis-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bronchitis Pipeline Appears Robust With 15+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight here
News-ID: 4081653 • Views: …
More Releases from DelveInsight Business Research LLP

Asthma Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in …
DelveInsight's, "Asthma Pipeline Insight 2025" report provides comprehensive insights about 80+ companies and 90+ pipeline drugs in Asthma pipeline landscape. It covers the Asthma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Asthma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Asthma Research. Learn more about our…

Non-Muscle Invasive Bladder Cancer Market: Epidemiology, Therapies, Companies, D …
Non-Muscle Invasive Bladder Cancer therapies are expected to boost the Non-Muscle Invasive Bladder Cancer Market in the upcoming years.
DelveInsight has launched a new report on "Non-Muscle Invasive Bladder Cancer - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Non-Muscle Invasive Bladder Cancer, historical and forecasted epidemiology as well as the Non-Muscle Invasive Bladder Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France,…

Nontuberculous Mycobacterial Infections Market: Epidemiology, Therapies, Compani …
Nontuberculous Mycobacterial Infections therapies, such as ARIKAYCE (amikacin liposome inhalation suspension), Epetraborole, MNKD-101 (Clofazimine Inhalation Suspension), SPR720 (Fobrepodacin), and others, are expected to boost the Nontuberculous Mycobacterial Infections Market in the upcoming years.
DelveInsight has launched a new report on "Nontuberculous Mycobacterial Infections - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Nontuberculous Mycobacterial Infections, historical and forecasted epidemiology as well as the Nontuberculous Mycobacterial Infections…

Cough in Idiopathic Pulmonary Fibrosis Market: Epidemiology, Therapies, Companie …
Cough in Idiopathic Pulmonary Fibrosis therapies, such as Orvepitant Maleate, Haduvio (nalbuphine ER), and others, are expected to boost the Cough in Idiopathic Pulmonary Fibrosis Market in the upcoming years.
DelveInsight has launched a new report on "Cough in Idiopathic Pulmonary Fibrosis - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Cough in Idiopathic Pulmonary Fibrosis, historical and forecasted epidemiology as well as the Cough in…
More Releases for Bronchitis
Bronchitis Market: Study Navigating the Future Growth Outlook
Global Bronchitis Market Report 2019 - Market Size, Share, Price, Trend and Forecast is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Bronchitis Market. Some of the key players profiled in the study are…
Bronchitis Treatment Market: Rising Morbidity & Mortality Rate Leads to Dominanc …
Cough has been one of the most common illness-related reason for ambulatory visits in the United States. As the cough linked with bronchitis is so troublesome and slow to resolve, patients seek treatment. The use of biomarkers in identifying patients who might reap benefit from antibiotics is popular. However, the American Academy of Pediatrics cautions against the use of use of antibiotics for apparent viral respiratory illness, including pharyngitis, bronchitis…
Global Bronchitis Drug Market Professional Survey Report 2018
This report studies Bronchitis Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
Request Sample Copy of the Business Report @ https://www.worldwidemarketreports.com/sample/111008
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Advanced Inhalation Therapies (AIT) Ltd,AstraZeneca Plc,DBV Technologies…
Trends in the Bronchitis Treatment Market 2016-2026
The chronic bronchitis is defined as the inflammation of the bronchi that lasts for more than 3 months for consecutive 2 years. The bronchi are the tubes which carry air in to the lungs. The major symptom of bronchitis is persistent cough associated with mucus expectoration, headache, nasal congestion, sore throat and fatigue. Risk factors for bronchitis include irritants, chemicals, air pollution and smoke. There are mainly two types of…
Chronic Bronchitis - Pipeline Research and Markets Insight, 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Chronic Bronchitis - Pipeline Insight, 2017”. This report provides comprehensive insights of the ongoing therapeutic research and development across Chronic Bronchitis.
Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1265427
The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Chronic Bronchitis by development stage, therapy…
Bronchitis Treatment Market Segments And Key Trends 2016-2026
The chronic bronchitis is defined as the inflammation of the bronchi that lasts for more than 3 months for consecutive 2 years. The bronchi are the tubes which carry air in to the lungs. The major symptom of bronchitis is persistent cough associated with mucus expectoration, headache, nasal congestion, sore throat and fatigue. Risk factors for bronchitis include irritants, chemicals, air pollution and smoke. There are mainly two types of…